Skip to main content
# Table 1 General features of 17 refractory idiopathic systemic autoimmune myopathies

From: Mycophenolate mofetil in patients with refractory systemic autoimmune myopathies: case series

No | Disease |
Disease (years) | Treatment | Activity | CPK (U/L) | Prednisone (mg/day)* | |||||
---|---|---|---|---|---|---|---|---|---|---|---|

Previous | Immediately Before MMF | Current | Initial | 6 months after MMF treatment | Initial | 6 months after MMF treatment | Inicial | 6 months after MMF treatment | |||

1 | PM | 2 | MP,Pred,Aza,CYC | CP | CP, MMF | P | P | 95 | 130 | 5.0 | 20.0 |

2 | DM | 2 | Pred,Aza,MTX,CYC | AZA | MMF | P | Remission | 48 | 66 | 15.0 | 5.0 |

3 | ASS | 1 | MP,Pred,IVIg,Aza,MTX,CYC | CYC | MMF | Mu,C,P | Mu | 242 | 139 | 20.0 | 10.0 |

4 | ASS | 2 | Pred,Aza,MTX,CYC | MTX | MTX, MMF | Mu,C | Remission | 167 | 200 | 10.0 | 5.0 |

5 | DM | 8 | Pred,AM,Aza,CP,RTX,Tac | AM,Tac | AM, Tac, MMF | Mu,C | C | 141 | 53 | 15.0 | 20.0 |

6 | DM | 3 | Pred,Aza,MTX | AZA | AZA, MMF | Mu,C | Mu | 268 | 148 | 15.0 | 7.5 |

7 | DM | 2 | MP,Pred,Aza,MTX | MTX | MMF | Mu | Mu | 40 | 20 | 50.0 | 30.0 |

8 | DM | 6 | MP,Pred,Aza,MTX,CP | MTX,CP | CP, MMF | Mu | Mu | 249 | 2120 | 10.0 | 15.0 |

9 | PM | 6 | MP,Pred,Aza,MTX | AZA | AZA, MMF | Mu | Mu | 1534 | 3517 | 5.0 | 0 |

10 | DM | 1 | MP,Pred,Aza,CYC,RTX | RTX | RTX, MMF | Mu | Mu | 215 | 255 | 15.0 | 2.5 |

11 | PM | 1 | Pred,Aza,MTX | - | MMF | Mu | Mu | 118 | 205 | 60.0 | 5.0 |

12 | DM | 1 | MP,AM,AZA,MTX | AZA | MMF | Mu | Mu | 35 | 30 | 40.0 | 5.0 |

13 | DM | 1 | MP,Pred,AZA,MTX | MTX | MTX, MMF | Mu | Remission | 245 | 257 | 10.0 | 0 |

14 | DM | 5 | MP,AM,AZA,MTX,CP | AZA,CP | AZA, MMF | Mu | Mu | 858 | 268 | 10.0 | 0 |

15 | DM | 1 | Pred,AZA,CYC | - | MMF | C,P | C | 114 | 138 | 15.0 | 5.0 |

16 | DM | 1 | MP,Pred,MTX | MTX | MTX, MMF | C | Remission | 100 | 80 | 12.5 | 5.0 |

17 | CADM | 3 | Pred,AZA,MTX,LFN,CYC | AZA,LFN | AZA, MMF | C | C | 79 | 95 | 60.0 | 2.5 |

2.0 (1.0-4.0) |
15.0 (10.0-30.0) |
5.0 (2.5-12.5) |